Achieve Life Sciences Inc (NAS:ACHV)
$ 5.48 0.27 (5.18%) Market Cap: 188.19 Mil Enterprise Value: 130.06 Mil PE Ratio: 0 PB Ratio: 3.81 GF Score: 37/100

Achieve Life Sciences Inc Clinical Development Update Call Transcript

Apr 27, 2022 / 12:30PM GMT
Release Date Price: $7.43 (+7.68%)
Operator

Ladies and gentlemen, thank you for standing by, and welcome to the Achieve Life Sciences ORCA-2 Clinical Data Results Conference Call. (Operator Instructions) Please be advised that today's conference is being recorded. (Operator Instructions) I would now like to hand the conference over to your speaker, Ms. Jaime Xinos. Please go ahead.

Jaime Xinos
Achieve Life Sciences, Inc. - EVP of Commercial

Thank you, Sheri, and thanks, everyone, for joining us. On the call today from Achieve, we have John Bencich, Chief Executive Officer; Dr. Cindy Jacobs, President and Chief Medical Officer; Rick Stewart, Executive Chairman of the Board of Directors; and Dr. Anthony Clarke, Chief Scientific Officer. Dr. Nancy Rigotti, Professor of Medicine at Harvard Medical School and Principal Investigator of the ORCA-2 trial is also joining for Q&A.

I'd like to remind everyone that today's conference call contains forward-looking statements based on current expectations. These statements are only predictions, and actual results may vary materially from those projected.

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investorsā€™ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot